GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Accumulated other comprehensive income (loss)

DuoGenic StemCells (ROCO:7607) Accumulated other comprehensive income (loss) : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. DuoGenic StemCells's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was NT$0.00 Mil.


DuoGenic StemCells Accumulated other comprehensive income (loss) Historical Data

The historical data trend for DuoGenic StemCells's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Accumulated other comprehensive income (loss) Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
- - - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


DuoGenic StemCells Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines